Atlas Trials

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

Clinical trial NCT00742690 · UNKNOWN

Trial details

NCT number
NCT00742690
Sponsor
University of Padova
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
CirrhosisType 1 Hepatorenal Syndrome
Start date
2005-05-01
Primary completion
2014-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.